Neoadjuvant chemotherapy for patients with osteosarcoma: University of Florida studies

Cancer Treat Res. 1993:62:339-46. doi: 10.1007/978-1-4615-3518-8_41.
No abstract available

Publication types

  • Clinical Trial
  • Comparative Study
  • Review

MeSH terms

  • Amputation, Surgical
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Bone Neoplasms / drug therapy
  • Bone Neoplasms / mortality
  • Bone Neoplasms / pathology
  • Bone Neoplasms / surgery
  • Bone Neoplasms / therapy*
  • Chemotherapy, Adjuvant
  • Cisplatin / administration & dosage
  • Combined Modality Therapy
  • Cyclophosphamide / administration & dosage
  • Doxorubicin / administration & dosage
  • Etoposide / administration & dosage
  • Florida / epidemiology
  • Humans
  • Infusions, Intra-Arterial
  • Infusions, Intravenous
  • Life Tables
  • Lung Neoplasms / drug therapy
  • Lung Neoplasms / radiotherapy
  • Lung Neoplasms / secondary
  • Methotrexate / administration & dosage
  • Osteosarcoma / drug therapy
  • Osteosarcoma / mortality
  • Osteosarcoma / pathology
  • Osteosarcoma / radiotherapy
  • Osteosarcoma / secondary
  • Osteosarcoma / surgery
  • Osteosarcoma / therapy*
  • Survival Analysis
  • Treatment Outcome

Substances

  • Etoposide
  • Doxorubicin
  • Cyclophosphamide
  • Cisplatin
  • Methotrexate